BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ryan R, Hill S, Lowe D, Allen K, Taylor M, Mead C. Notification and support for people exposed to the risk of Creutzfeldt-Jakob disease (CJD) (or other prion diseases) through medical treatment (iatrogenically). Cochrane Database Syst Rev 2011;:CD007578. [PMID: 21412905 DOI: 10.1002/14651858.CD007578.pub2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Reynolds CA, Yawitch T, Hewitt PE, Harvala H. Blood donor notification of variant Creutzfeldt-Jakob disease risk: Lessons in communicating donor deferral and risk. Transfus Med 2022. [PMID: 35751157 DOI: 10.1111/tme.12891] [Reference Citation Analysis]
2 Gorst SL, Armitage CJ, Brownsell S, Hawley MS. Home telehealth uptake and continued use among heart failure and chronic obstructive pulmonary disease patients: a systematic review. Ann Behav Med 2014;48:323-36. [PMID: 24763972 DOI: 10.1007/s12160-014-9607-x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 65] [Article Influence: 12.6] [Reference Citation Analysis]
3 Hannes K, Booth A, Harris J, Noyes J. Celebrating methodological challenges and changes: reflecting on the emergence and importance of the role of qualitative evidence in Cochrane reviews. Syst Rev 2013;2:84. [PMID: 24135194 DOI: 10.1186/2046-4053-2-84] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
4 Bechtel K, Geschwind MD. Ethics in prion disease. Prog Neurobiol 2013;110:29-44. [PMID: 23906487 DOI: 10.1016/j.pneurobio.2013.07.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
5 Andrychowski J, Jasielski P, Netczuk T, Czernicki Z. Empyema in spinal canal in thoracic region, abscesses in paravertebral space, spondylitis: in clinical course of zoonosis Erysipelothrix rhusiopathiae. Eur Spine J 2012;21 Suppl 4:S557-63. [PMID: 22526696 DOI: 10.1007/s00586-012-2289-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]